Our MR analysis did not reveal any significant associations between circulating inflammatory biomarkers and liver cancer, with an OR of 1.13 (95% CI 0.81–1.57) for CRP, 0.82 (95% CI 0.59–1.14) for leukocyte count, 0.82 (95% CI 0.63–1.07) for eosinophil count, 1.53 (95% CI 0.93–2.51) for basophil count, 0.80 (95% CI 0.56–1.15) for neutrophil count, 0.81 (95% CI 0.59–1.10) for lymphocyte count, and 0.93 (95% CI 0.74–1.16) for monocyte count (Figure 3). The gene discussed is CRP; the disease is liver cancer.